| References |
Top |
| REF 1 |
Identification of SH3 domain interaction partners of human FasL (CD178) by phage display screening. BMC Immunol. 2009 Oct 6;10:53.
|
| REF 2 |
Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligand. Arch Biochem Biophys. 2002 Dec 15;408(2):155-61.
|
| REF 3 |
Cytoskeleton-mediated death receptor and ligand concentration in lipid rafts forms apoptosis-promoting clusters in cancer chemotherapy. J Biol Chem. 2005 Mar 25;280(12):11641-7.
|
| REF 4 |
Extracellular matrix interacts with soluble CD95L: retention and enhancement of cytotoxicity. Nat Immunol. 2001 Apr;2(4):333-7.
|
| REF 5 |
Identification of amino acid residues important for ligand binding to Fas. J Exp Med. 1997 Apr 21;185(8):1487-92.
|
| REF 6 |
Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation. Immunity. 2003 May;18(5):655-64.
|
| REF 7 |
Multiple interactions of the cytosolic polyproline region of the CD95 ligand: hints for the reverse signal transduction capacity of a death factor. FEBS Lett. 2001 Dec 7;509(2):255-62.
|
